Healthcare provider profile · identity verified

Gilbert C Rice, DO

Family Practice · HARRISONBURG, VA · NPI 1033347620

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	537	175
Amlodipine Besylate	Amlodipine Besylate	431	135
Lisinopril	Lisinopril	325	112
Rosuvastatin Calcium	Rosuvastatin Calcium	284	95
Omeprazole	Omeprazole	263	77
Levothyroxine Sodium	Levothyroxine Sodium	259	77
Losartan Potassium	Losartan Potassium	229	71
Hydrochlorothiazide	Hydrochlorothiazide	226	74
Metoprolol Succinate	Metoprolol Succinate	169	58
Metformin Hcl	Metformin Hcl	167	57
Simvastatin	Simvastatin	163	60
Furosemide	Furosemide	157	59
Pantoprazole Sodium	Pantoprazole Sodium	134	43
Albuterol Sulfate Hfa	Albuterol Sulfate	132	57
Gabapentin	Gabapentin	132	34
Duloxetine Hcl	Duloxetine Hcl	119	35
Montelukast Sodium	Montelukast Sodium	118	32
Meloxicam	Meloxicam	116	47
Tamsulosin Hcl	Tamsulosin Hcl	116	37
Sertraline Hcl	Sertraline Hcl	111	37
Trazodone Hcl	Trazodone Hcl	110	33
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	109	40
Escitalopram Oxalate	Escitalopram Oxalate	103	33
Metoprolol Tartrate	Metoprolol Tartrate	97	33
Ezetimibe	Ezetimibe	95	28
Venlafaxine Hcl Er	Venlafaxine Hcl	91	17
Allopurinol	Allopurinol	88	30
Azithromycin	Azithromycin	83	74
Levofloxacin	Levofloxacin	79	62
Carvedilol	Carvedilol	71	24
Clopidogrel	Clopidogrel Bisulfate	67	23
Buspirone Hcl	Buspirone Hcl	66	19
Alprazolam	Alprazolam	62	14
Diclofenac Sodium	Diclofenac Sodium	62	16
Prednisone	Prednisone	61	43
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	57	18
Jardiance	Empagliflozin	55	18
Metformin Hcl Er	Metformin Hcl	55	15
Famotidine	Famotidine	54	14
Fluticasone Propionate	Fluticasone Propionate	47	12
Pravastatin Sodium	Pravastatin Sodium	47	12
Synthroid	Levothyroxine Sodium	47	14
Eliquis	Apixaban	45	17
Januvia	Sitagliptin Phosphate	45	suppressed
Warfarin Sodium	Warfarin Sodium	43	suppressed
Nabumetone	Nabumetone	41	16
Potassium Chloride	Potassium Chloride	38	15
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	37	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	37	13
Nifedipine Er	Nifedipine	36	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	35	12
Tramadol Hcl	Tramadol Hcl	35	suppressed
Xarelto	Rivaroxaban	35	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	34	30
Clonazepam	Clonazepam	34	suppressed
Glimepiride	Glimepiride	33	14
Spironolactone	Spironolactone	32	suppressed
Tizanidine Hcl	Tizanidine Hcl	32	18
Chlorthalidone	Chlorthalidone	30	11
Pregabalin	Pregabalin	29	12
Trulicity	Dulaglutide	28	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	27	24
Alendronate Sodium	Alendronate Sodium	26	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	25	suppressed
Ropinirole Hcl	Ropinirole Hcl	23	suppressed
Finasteride	Finasteride	22	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	22	11
Ozempic	Semaglutide	22	suppressed
Ondansetron Hcl	Ondansetron Hcl	20	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	20	suppressed
Citalopram Hbr	Citalopram Hydrobromide	19	suppressed
Clindamycin Hcl	Clindamycin Hcl	19	17
Esomeprazole Magnesium	Esomeprazole Magnesium	19	suppressed
Nebivolol Hcl	Nebivolol Hcl	19	suppressed
Breo Ellipta	Fluticasone/Vilanterol	18	suppressed
Paroxetine Hcl	Paroxetine Hcl	18	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	18	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	18	suppressed
Bupropion Xl	Bupropion Hcl	17	suppressed
Cephalexin	Cephalexin	17	14
Eszopiclone	Eszopiclone	17	suppressed
Glipizide	Glipizide	17	suppressed
Lansoprazole	Lansoprazole	17	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	17	suppressed
Phenobarbital	Phenobarbital	17	suppressed
Atenolol	Atenolol	16	suppressed
Fluconazole	Fluconazole	16	12
Fluoxetine Hcl	Fluoxetine Hcl	16	suppressed
Novolog Flexpen	Insulin Aspart	16	suppressed
Nystatin	Nystatin	16	suppressed
Propranolol Hcl	Propranolol Hcl	16	suppressed
Tresiba Flextouch U-100	Insulin Degludec	16	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	15	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	15	suppressed
Topiramate	Topiramate	15	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	15	13
Valsartan	Valsartan	15	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	14	suppressed
Diazepam	Diazepam	14	suppressed
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	14	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	14	suppressed
Symbicort	Budesonide/Formoterol Fumarate	14	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	14	suppressed
Vascepa	Icosapent Ethyl	14	suppressed
Verapamil Er	Verapamil Hcl	14	suppressed
Butalb-Acetaminoph-Caff-Codein	Butalbit/Acetamin/Caff/Codeine	13	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	13	suppressed
Lorazepam	Lorazepam	13	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	13	suppressed
Oxycodone Hcl	Oxycodone Hcl	13	suppressed
Solifenacin Succinate	Solifenacin Succinate	13	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	13	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	12	suppressed
Fenofibrate	Fenofibrate,micronized	12	suppressed
Glipizide Er	Glipizide	12	suppressed
Irbesartan	Irbesartan	12	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	12	suppressed
Motegrity	Prucalopride Succinate	12	suppressed
Valacyclovir	Valacyclovir Hcl	12	suppressed
Breyna	Budesonide/Formoterol Fumarate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error